Patent · US Active

Colonic purgative composition with soluble binding agent

US8507009B2 · kind B2 · utility

9Cited by
17References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 20, 2010
Grant dateAug 13, 2013
Priority date
Expiry dateJul 4, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to novel colonic purgative compositions in a solid dosage form, comprising at least one purgative and at least one soluble, or soluble, nonfermentable binder, such as polyethylene glycol. Further, this invention relates to methods of using the colonic purgative compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time improving the quality of bowel cleansing. The formulations and methods of this invention are particularly useful to cleanse the bowel prior to diagnostic and surgical procedures and can also be employed in lower dosages as a laxative to promote elimination and/or to relieve constipation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.